Dermata Therapeutics Inc（DRMA）價格預測

$1.300

+0.010 (+0.78%)收盤時

價格預測

1-Day Price Prediction

+1.41%

1-Week Prediction

+0.60%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

DRMA 相似圖表分析預測

Alphio's DRMA stock price prediction model matches the current Dermata Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.32 (+1.41%). The 1-week path is $1.31 (+0.60%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

該買進 Dermata Therapeutics Inc 股票嗎？

Dermata Therapeutics is not a good buy right now due to a current price of $1.34, which is significantly below the analyst's price target of $4. Additionally, the RSI is at 38.725, indicating potential oversold conditions but also a lack of upward momentum. The company reported a net loss of $2.97 million in Q2 2026, which is a widening loss from the previous year, highlighting ongoing financial struggles.

DRMA 股價於 Tuesday 收在 $1.30，此前上漲 +0.78%

Dermata Therapeutics Inc (DRMA) last closed at $1.3, gaining +0.78%. These facts feed the 1-day and 1-week DRMA price prediction above.

預測驅動因素

Dermata Therapeutics Inc（DRMA）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

相似圖表形態

近期走勢與 DRMA 最接近的股票，依相似度排序。

ARCT

88.69%

+10.36%

APTV

88.69%

+9.99%

ORCL

88.17%

-15.00%

AXTA

88.07%

-7.77%

SLS

87.35%

-23.56%

DRMA 季節性分析

Historically the probability of a positive September return for DRMA is 0.00%. January offers the highest probability of a positive month at 29.51%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…